Abstract
BackgroundJAK inhibitor uptake has increased in recent years, and recent NICE (National Institute for Health and Care Excellence) approval of certain JAK inhibitors for moderate rheumatoid arthritis disease activity will...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have